8.600
−9,47%
2026-10-09
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -95.5% | -70.2% | 1 / 3 | +77.3% | -6.69 pp | -4.61 pp | -5.6% | 2.16 | — | 98,6 | +77,3% | 0,1 | −95,5% | — | 29.99 | — |
| Pts | 0 | 0 | 4 | 12 | 0 | 0 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 8.600 (close price on 2026-10-09)EPS (TTM): −638,2
Financial charts
1.Revenue & growth
VND bn98,6Q2/26
1.Revenue & growth
VND bn98,6Q2/26
2.Profit & growth
VND bn0,12Q2/26
3.Profit mix (Penman)
VND bn-3,19Q2/26
4.Margins & cost structure
%6.6%Q2/26
5.Returns & cash cycle
% · days3.9%Q2/26
6.Earnings quality & cash
VND bn-20,7Q2/26
7.Asset structure
VND bn310Q2/26
8.Funding & debt health
VND bn · times310Q2/26
9.Revenue backlog
VND bn84,7Q2/26
10.Valuation
times · %-16,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %24Q2/26
Adjusted EPS growth, latest quarter
-95.5%
Average adjusted EPS growth, 3 quarters
-33.1%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26